USANA Health Sciences, Inc.
Consumer DefensiveNYSE:USNA · New York Stock Exchange
+$0.04 today
Vol 0.08M · Avg 0.12M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$925.9M of revenue converted into $8.9M of net income for the selected period. Gross margin is 76.7% and net margin is 0.8%, showing how much revenue survives after costs and taxes. EPS is $0.47, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $925.3M +8.3% | $854.5M -7.2% | $921.0M -7.8% | $998.6M -15.8% | $1.2B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $200.9M +14.3% | $175.8M -7.2% | $189.4M -8.6% | $207.3M -10.2% | $230.9M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $724.4M +6.7% | $678.8M -7.2% | $731.6M -7.5% | $791.3M -17.2% | $955.5M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 78.3% -1.1pp | 79.4% -0.0pp | 79.4% +0.2pp | 79.2% -1.3pp | 80.5% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 -100.0% | $11.6M +1.1% | $11.4M -1.0% | $11.6M +4.1% | $11.1M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $337.4M -43.9% | $600.9M -4.2% | $627.1M -6.7% | $672.1M -13.2% | $774.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $673.5M +10.0% | $612.4M -4.1% | $638.5M -6.6% | $683.7M -12.9% | $785.3M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $39.7M +78.6% | $22.2M +9.0% | $20.4M -4.7% | $21.4M -3.5% | $22.2M | $374.2M | $1.2B | $631.8M |
| EBITDA | $82.1M -17.0% | $98.9M -19.7% | $123.1M -5.5% | $130.2M -32.5% | $192.9M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 8.9% -2.7pp | 11.6% -1.8pp | 13.4% +0.3pp | 13.0% -3.2pp | 16.3% | 5.6% | 46.3% | 42.0% |
| Operating Income | $50.9M -23.3% | $66.3M -28.7% | $93.1M -13.5% | $107.6M -36.8% | $170.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 5.5% -2.3pp | 7.8% -2.3pp | 10.1% -0.7pp | 10.8% -3.6pp | 14.3% | 16.6% | 24.1% | 22.0% |
| Interest Income | $2.4M -78.7% | $11.3M +17.5% | $9.6M +154.3% | $3.8M +50.7% | $2.5M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $842.0K +199.6% | $281.0K +7.3% | $262.0K +36.5% | $192.0K +236.8% | $57.0K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$9.3M -193.1% | $10.0M +6.9% | $9.4M +831.7% | $1.0M +123.8% | $450.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $41.5M -45.6% | $76.4M -25.5% | $102.5M -5.7% | $108.6M -36.3% | $170.6M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 4.5% -4.4pp | 8.9% -2.2pp | 11.1% +0.2pp | 10.9% -3.5pp | 14.4% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $30.1M -12.4% | $34.3M -11.3% | $38.7M -1.5% | $39.3M -27.5% | $54.1M | $1.3B | -$1.6B | $745.2M |
| Net Income | $10.8M -74.4% | $42.0M -34.1% | $63.8M -8.0% | $69.3M -40.5% | $116.5M | $4.9B | $4.8B | $4.7B |
| Net Margin | 1.2% -3.8pp | 4.9% -2.0pp | 6.9% -0.0pp | 6.9% -2.9pp | 9.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 -73.6% | $2 -33.9% | $3 -7.5% | $4 -37.7% | $6 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 -73.5% | $2 -33.6% | $3 -8.1% | $4 -37.3% | $6 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $18.6M -2.6% | $19.1M -1.0% | $19.3M -0.0% | $19.3M -4.4% | $20.1M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $18.6M -3.1% | $19.2M -0.9% | $19.3M +0.2% | $19.3M -5.1% | $20.3M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Westrock Coffee Company, LLC
NASDAQ:WEST
$926.80M
Mama's Creations, Inc.
NASDAQ:MAMA
$606.94M
Dingdong (Cayman) Limited
NYSE:DDL
$521.92M
Calavo Growers, Inc.
CVGW
$466.33M
Vasta Platform Limited
VSTA
$394.00M
Lifeway Foods, Inc.
NASDAQ:LWAY
$383.12M
BrasilAgro - Companhia Brasileira de Propriedades Agrícolas
NYSE:LND
$372.56M
B&G Foods, Inc.
NYSE:BGS
$327.10M
QuantaSing Group Ltd
QSG
$274.08M
BRC Inc.
NYSE:BRCC
$159.13M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does USNA generate?
USANA Health Sciences, Inc. (USNA) reported $925.26M of revenue in fiscal 2025.
Is USNA profitable?
USANA Health Sciences, Inc. (USNA) reported $10.76M of net income, with a net margin of 1.2%.
Explore More
Continue the stock analysis
Jump to another research area for this company.